NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors

• Asıl Yazarlar: Michelle X. Yang (Yazar), Ryan F. Coates (Yazar), Abiy Ambaye (Yazar), Valerie Cortright (Yazar), Jeannette M. Mitchell (Yazar), Alexa M. Buskey (Yazar), Richard Zubarik (Yazar), James G. Liu (Yazar), Steven Ades (Yazar), Maura M. Barry (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: BMC, 2018-04-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Background Well-differentiated neuroendocrine tumors (NET) most frequently arise from the gastrointestinal tract (GI), pancreas, and lung. Patients often present as metastasis with an unknown primary, and the clinical management and outcome depend on multiple factors, including the accurate...